Structural magnetic resonance imaging in schizophrenia: An overview;Aktueller überblick über strukturelle magnetresonanztomographie bei schizophrenie

Fortschritte der Neurologie Psychiatrie

Volumn 69, Issue 3, 2001, Pages 105-115

  Schmitt, A ^a   Weber Fahr, W ^a   Jatzko, A ^a   Tost, H ^a   Henn, F A ^a   Braus, D F ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ARTICLE; BRAIN SIZE; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE DEGENERATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SYMPTOMATOLOGY; PATHOLOGY; REVIEW;

HUMANS; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA;

EID: 0035081098     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12277     Document Type: Article

References (170)

1. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
2. A neurohistological correlate of schizophrenia
3. Nonlinear spatial normalization using basis functions
4. Reduced gray matter volume in schizophrenia
5. MRI correlates of treatment response in first episode psychosis
6. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms
7. Gray matter deficits in young onset schizophrenia are independent of age of onset
8. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease
9. The neuropathology of schizophrenia. A critical review of the data and their interpretation
10. The temporolimbic system theory of positive schizophrenic symptoms
11. Does an increase in sulcal or ventricular fluid predict where brain tissue is lost?
12. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype
13. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset
14. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital
15. Identifying global anatomical differences: Deformation-based morphometry
16. A neurodevelopmental approach to the classification of schizophrenia
17. Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study
18. MRI anatomy of schizophrenia
19. Metaanalysis of regional brain volumes in schizophrenia
20. Cognitive dysfunction in schizophrenia: Unifying basic research and clinical aspects
21. Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia
22. Superior temporal gyrus in schizophrenia: A volumetric magnetic resonance imaging study
23. Posterior superior temporal gyrus in schizophrenia: Grey matter changes and clinical correlates
24. Planum temporale asymmetry and thought disorder in schizophrenia
25. Reversal of asymmetry of the planum temporale in schizophrenia
26. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia
27. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia
28. Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study
29. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
30. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions
31. Cell biology of the hippocampal formation in schizophrenia
32. Size, shape, and orientation of neurons in the left and right hippocampus: Investigation of normal asymmetries and alterations in schizophrenia
33. Human hippocampus associates information in memory
34. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia
35. The neurodevelopmental theory of schizophrenia: Evidence concerning structure and neuropsychology
36. Cognitive deficits in schizophrenia
37. Assessment of differential attention mechanism in seizure disorders and schizophrenia
38. Cognitive functioning and neuroanatomic volume measures in schizophrenia
39. Inverse relationship of perinatal complications and eye tracking dysfunction in relatives of patients with schizophrenia: Evidence for a two-factor model
40. 2O PET study during single-trial Stroop task performance
41. Functional hypofrontality and working memory dysfunction in schizophrenia
42. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia
43. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
44. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia
45. Increase of phosphodiesters during neuroleptic treatment of schizophrenics: A longitudinal 31P-magnetic resonance spectroscopic study
46. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics - A study including 50 patients and 36 controls
47. Absence of regional hemispheric volume asymmetries in frst-episode schizophrenia
48. Cingulate gyrus in schizophrenic patients and normal volunteers
49. Volumetric analysis of frontal lobe regions in schizophrenia: Relation to cognitive function and symptomatology
50. Relationship of prefrontal and temporal lobe MRI measures of neuropsychological performance in chronic schizophrenia
51. Schizophrenia and the frontal brain: A quantitative review
52. Decreased regional cortical gray matter volume in schizophrenia
53. Schizophrenia: A disease of heteromodal association cortex?
54. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging
55. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia
56. Volumetric MRI assessment of temporal lobe structures in schizophrenia
57. Sex differences in inferior parietal lobule volume in schizophrenia
58. Brain morphology in first-episode schizophrenia
59. A profile of cortical gray matter volume deficits characteristic of schizophrenia
60. Patterns of cerebral blood flow in schizophrenia
61. Schizophrenia, the heteromodal association neocortex and development: Potential for a neurogenetic approach
62. Neurobiologie der schizophrenie
63. Schizophrenia: Developmental disturbance of brain and mind?
64. Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
65. Neuropathology of schizophrenia: Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems
66. Basal ganglia pathology in schizophrenia and tardive dyskinesia: An MRI quantitative study
67. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
68. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum
69. The thalamus as a site of action of antipsychotic drugs
70. Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research
71. PET and MRI of the thalamus in never-medicated patients with schizophrenia
72. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics
73. The size and fiber composition of the anterior commissure with respect to gender and schizophrenia
74. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: A positron emission tomography study
75. Prefrontal cortex projections to the basilar pons in rhesus monkey: Implications for the cerebellar contribution to higher function
76. Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms
77. An MRI study of cerebellar vermis morphology in patients with schizophrenia: Evidence in support of the cognitive dysmetria concept
78. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia
79. Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia
80. Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia
81. Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: Clinical and cognitive correlates
82. Memory functions and temporal-limbic morphology in schizophrenia
83. Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study
84. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
85. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings
86. Progression of cerebroventricular enlargement and the subtyping of schizophrenia
87. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures
88. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism
89. Funktionelle magnetresonanztomographie in der psychopathologischen forschung
90. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
91. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia
92. Atypical vs. typical neuroleptics: A combined fMRI and MRSI study in schizophrenic patients
93. Funktionelle kernspintomographie und schizophrenie: Medikamenteneffekte, methodische grenzen und perspektiven
94. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients
95. Structural magnetic resonance image averaging in schizophrenia
96. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia
97. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls
98. Temporal lobe morphology in childhood-onset schizophrenia
99. Hippocampal volume reduction in male schizophrenic patients
100. Structural brain abnormalities in patients with schizophrenia and their healthy siblings
101. An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects
102. Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia
103. Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness
104. Corpus callosum size in schizophrenia - A magnetic resonance imaging analysis
105. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia
106. Language and thought disorder in schizophrenia: Brain morphological correlates
107. Planum temporale asymmetry reversal in schizophrenia: Replication and relationship to gray matter abnormalities
108. Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia
109. Brain abnormalities in schizophrenia-spectrum children: Implications for a neurodevelopmental perspective
110. Deficits in gray matter volume are present in schizophrenia but not bipolar disorder
111. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects
112. Cerebral gray matter volume deficits in first episode psychosis
113. Similar extent of brain dysmorphology in severely ill women and men with schizophrenia
114. Cortical gray matter volume deficit in patients with firstepisode schizophrenia
115. Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia
116. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls
117. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging
118. Brain morphometric comparison of first-episode schizophrenia and temporal lobe epilepsy
119. Structural brain abnormalities in male schizophrenics reflect frontotemporal dissociation
120. Temporal horn enlargement in present in schizophrenia and bipolar disorder
121. Ventricular enlargement in poor-outcome schizophrenia
122. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: An MRI-based morphometric analysis
123. Neuromorphological abnormalities in schizophrenic patients with good and poor outcome
124. Fine volumetric analysis of the cerebral ventricular system in schizophrenia: Further evidence for multi focal mild to moderate enlargement
125. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia
126. Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging
127. Is the course of brain development in schizophrenia delayed? Evidence from onsets in adolescence
128. Cumulative effect of anatomical risk factors for schizophrenia an MRI study
129. Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia
130. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia
131. MRI brain abnormalities in chronic schizophrenia: One process or more?
132. Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi
133. Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: Assessment by MRI
134. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia
135. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study
136. Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia
137. Hippocampal volume reduction in schizophrenia: Effects of genetic risk and pregnancy and birth complications
138. Hippocampal volume in first-episode psychoses and chronic schizophrenia: A high-resolution magnetic resonance imaging study
139. Hippocampal pathology in schizophrenia: Magnetic resonance imaging and spectroscopy studies
140. Abnormalities of auditory evoked magnetic fields and structural changes in the left hemisphere of male schizophrenics - A magnetoencephalographic-magnetic resonance imaging study
141. Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?
142. Superior temporal gyrus volume abnormalities and thought disorder in left-handed schizophrenic men
143. Striatal dopamine D2 receptor quantification and superior temporal gyrus: Volume determination in 14 chronic schizophrenic subjects
144. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: Measures of the planum temporale and superior temporal gyrus by MRI
145. Left planum temporale volume reduction in schizophrenia
146. Superior temporal gyrus volume in schizophrenia: A study using MRI morphometry assisted by surface rendering
147. Planum temporale and Heschl gyrus volume reduction in schizophrenia: A magnetic resonance imaging study of first-episode patients
148. In vivo morphometry of planum temporale asymmetry in first-episode schizophrenia
149. Structural evaluation of the prefrontal cortex in schizophrenia
150. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging
151. Temporal lobe sulco-gyral pattern anomalies in schizophrenia: An in vivo MR three-dimensional surface rendering study
152. Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study
153. Subgenual cingulate cortex volume in first-episode psychosis
154. Thalami abnormalities in schizophrenia visualized through magnetic resonance image averaging
155. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum
156. A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls
157. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging
158. The thalamus and the schizophrenia phenotype: Failure to replicate reduced volume
159. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking anti-psychotic drugs
160. Caudate, putamen, and globus pallidus volume in schizophrenia: A quantitative MRI study
161. Decreased caudate volume in neuroleptic-naive psychotic patients
162. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia
163. Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
164. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network
165. Gender differences in corpus callosum size in first-episode schizophrenics
166. Landmark analysis of corpus callosum shape in schizophrenia
167. Corpus callosum shape and size in male patients with schizophrenia
168. Anatomical characteristics of the corpus callosum and clinical correlates in schizophrenia
169. Corpus callosum size and inter-hemispheric function in schizophrenia